Search results for "Smoking Cessation"
Increased doses of smoking cessation therapy improved quit rates following treatment failure
Raising doses of varenicline or nicotine replacement therapy increased abstinence rates in patients for whom an initial dose of varenicline or combined nicotine replacement therapy was ineffective, a two-part trial found.
https://immattersacp.org/weekly/archives/2024/05/07/2.htm
7 May 2024
Take a team approach to coronary disease
A major update to a cardiology guideline puts team-based, patient-centered care at the forefront of management and highlights the role of healthy diet and exercise habits in reducing cardiovascular risk.
https://immattersacp.org/archives/2024/02/take-a-team-approach-to-coronary-disease.htm
1 Feb 2024
Likelihood of smoking cessation after cardiovascular event varies by event type
Patients who had had a myocardial infarction, coronary artery bypass grafting, stroke, or transient ischemic attack were more likely to quit smoking than those who underwent elective percutaneous coronary intervention or had a new diagnosis of peripheral artery disease.
https://immattersacp.org/weekly/archives/2024/02/13/4.htm
13 Feb 2024
Making smoking cessation less of a struggle
This month's issue considers smoking cessation, helping patients with disabilities, and conference coverage from the Society of Hospital Medicine's annual meeting.
https://immattersacp.org/archives/2022/06/making-smoking-cessation-less-of-a-struggle.htm
1 Jun 2022
Repeated tobacco screening linked to higher likelihood of smoking cessation treatment
The average adjusted predicted probability of prescription and/or referral for smoking cessation rose from 13.7% among current and former smokers screened once to 41.7% among those screened five or six times, a study of Veterans Affairs primary care clinics found.
https://immattersacp.org/weekly/archives/2023/06/13/4.htm
13 Jun 2023
Cytisinicline shows promise for smoking cessation in industry-funded trial
In a phase 3 randomized controlled trial, both six- and 12-week courses of cytisinicline, an investigational drug, led to higher rates of continuous smoking abstinence compared with placebo.
https://immattersacp.org/weekly/archives/2023/07/18/1.htm
18 Jul 2023
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, I.M. Matters Weekly from ACP.
https://immattersacp.org/archives/2024/03/latest-updates-on-acps-priorities-initiatives.htm
1 Mar 2024
ATS guideline strongly recommends varenicline for smoking cessation
A new clinical practice guideline from the American Thoracic Society (ATS) made five strong recommendations and two conditional recommendations regarding medications to treat adults with tobacco dependence.
https://immattersacp.org/weekly/archives/2020/07/21/3.htm
21 Jul 2020
Combating the crisis of loneliness
While the COVID-19 pandemic put a spotlight on loneliness, social engagement with friends and family has been falling for the past two decades as feelings of social isolation have increased.
https://immattersacp.org/archives/2023/10/combating-the-crisis-of-loneliness.htm
1 Oct 2023
Adding nicotine replacement therapy to varenicline monotherapy didn't increase smoking cessation
In a randomized trial of 1,251 adults who smoked five or more cigarettes per day, neither varenicline plus a nicotine patch nor extended-duration treatment was superior to 12 weeks of varenicline monotherapy for abstinence.
https://immattersacp.org/weekly/archives/2021/10/26/2.htm
26 Oct 2021